Education
About Us
Working with TipRanks
Follow Us
Sinopharm Tech Holdings Limited (HK:8156)
:8156
RESEARCH TOOLSreports
Total Valuation
Sinopharm Tech Holdings Limited has a market cap or net worth of HK$78.58M. The enterprise value is HK$73.65M.
Market CapHK$78.58M
Enterprise ValueHK$73.65M
Share Statistics
Sinopharm Tech Holdings Limited has 633,693,050 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding633,693,050
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sinopharm Tech Holdings Limited’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.95%.
Return on Equity (ROE)0.10
Return on Assets (ROA)-0.44
Return on Invested Capital (ROIC)6.95%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee1.38M
Profits Per Employee-669.53K
Employee Count30
Asset Turnover0.93
Inventory Turnover10.25
Valuation Ratios
The current PE Ratio of Sinopharm Tech Holdings Limited is -1.03. Sinopharm Tech Holdings Limited’s PEG ratio is -0.07.
PE Ratio-1.03
PS Ratio0.00
PB Ratio-2.05
Price to Fair Value-0.10
Price to FCF-33.83
Price to Operating Cash Flow-13.59
PEG Ratio-0.07
Income Statement
In the last 12 months, Sinopharm Tech Holdings Limited had revenue of 41.28M and earned -19.70M in profits. Earnings per share was -0.11.
Revenue41.28M
Gross Profit5.02M
Operating Income-9.16M
Pretax Income-20.33M
Net Income-19.70M
EBITDA4.98M
Earnings Per Share (EPS)-0.11
Cash Flow
In the last 12 months, operating cash flow was -781.00K and capital expenditures 0.00, giving a free cash flow of -781.00K billion.
Operating Cash Flow-781.00K
Free Cash Flow-781.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
Sinopharm Tech Holdings Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.03
52-Week Price Change20.00%
50-Day Moving Average0.11
200-Day Moving Average0.10
Relative Strength Index (RSI)58.20
Average Volume (3m)54.10K
Important Dates
Sinopharm Tech Holdings Limited upcoming earnings date is Sep 26, 2025, TBA Not Confirmed.
Last Earnings DateFeb 28, 2025
Next Earnings DateSep 26, 2025
Ex-Dividend Date―
Financial Position
Sinopharm Tech Holdings Limited as a current ratio of 0.15, with Debt / Equity ratio of -43.31%
Current Ratio0.15
Quick Ratio0.14
Debt to Market Cap3.56
Net Debt to EBITDA14.18
Interest Coverage Ratio-0.38
Taxes
In the past 12 months, Sinopharm Tech Holdings Limited has paid 83.00K in taxes.
Income Tax83.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Sinopharm Tech Holdings Limited EV to EBITDA ratio is 18.24, with an EV/FCF ratio of -7.22.
EV to Sales2.20
EV to EBITDA18.24
EV to Free Cash Flow-7.22
EV to Operating Cash Flow-9.82
Balance Sheet
Sinopharm Tech Holdings Limited has HK$3.35M in cash and marketable securities with HK$6.03M in debt, giving a net cash position of HK$2.68M billion.
Cash & Marketable SecuritiesHK$3.35M
Total DebtHK$6.03M
Net CashHK$2.68M
Net Cash Per Share<HK$0.01
Tangible Book Value Per Share-HK$1.12
Margins
Gross margin is 23.66%, with operating margin of -22.20%, and net profit margin of -47.72%.
Gross Margin23.66%
Operating Margin-22.20%
Pretax Margin-49.26%
Net Profit Margin-47.72%
EBITDA Margin12.06%
EBIT Margin8.72%
Analyst Forecast
The average price target for Sinopharm Tech Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-11.42%
EPS Growth Forecast26.75%